Phase 3 randomized study of loncastuximab tesirine in combination with rituximab (Lonca-R) versus immunochemotherapy in patients with R/R DLBCL (LOTIS-5).Mehdi Hamadani,Yuliya Linhares, Mitul Gandhi,Michael Chung, Helena Adamis,David Ungar,Carmelo Carlo-Stella, Ed Kingsley, Julien Depaus,Sylvia Snauwaert, Michal Kwiatek, Javier Lopez-JimenezHemaSphere(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要